Effectiveness Questioned: Study Finds That Paxlovid Fails To

Researchers at UCSF have discovered an unexpectedly high rate of COVID rebound following treatment with Paxlovid. A group of scientists from the University of California, San Francisco, discovered that Paxlovid (Nirmatrelvir-ritonavir) was ineffective in lowering the chances of vaccinated, non-hosp

Related Keywords

San Francisco , California , United States , Carmen Isasi , Steveng Deeks , Noahd Peyser , Markj Pletcher , Matthew Durstenfeld , Jeffreye Olgin , Timothyj Henrich , Feng Lin , Michaelj Peluso , Matthews Durstenfeld , Alexisl Beatty , Gregorym Marcus , University Of California , Melinda Gates Foundation , Eureka Research Platform , Outcomes Research Institute , Science Study , Patient Centered Outcomes Research Institute ,